Title 21 Job Opportunities
The 21st Century Cures Act was enacted on December 13, 2016 and Section 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products. The FY23 Food and Drug Omnibus Reform Act expanded this authority further amending Title 21 to include cross-cutting operational positions and individuals that support the development review and regulation of food and cosmetics in addition medical products. (codified into Title 21 of the United States Code (21 US Code 379d-3a).
The positions listed below are being filled under Title 21. The candidate selected for these positions will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here
Title 21 Open Vacancies
Branch Chief
Center for Biologics Evaluation and Research (CBER)
Closing date: May 7, 2024
Regulatory Health Project Manager
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 3, 2024
Regulatory Specialist
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 6, 2024
Pharmacist
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 3, 2024
Consumer Affairs Branch Chief
Center for Biologics Evaluation and Research (CBER)
Closing date: May 5, 2024
Supervisory AD for Risk Evaluation and Mitigation Strategies
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 3, 2024
Human Capital Director
Center for Devices and Radiological Health (CDRH)
Closing date: April 30, 2024
Project Manager
Center for Biologics Evaluation and Research (CBER)
Closing date: April 24, 2024
Supervisory Regulatory Health Project Manager
The Center for Drug Evaluation and Research (CDER)
Closing Date: April 26, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Associate Commissioner for Minority Health Office of the Commissioner (OC)
Closing date: April 23, 2024
Deputy Office Director (Supervisory Consumer Safety Officer) (AD-0696)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 1, 2024
Deputy Office Director (Supervisory Regulatory Counsel) (AD-0301)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 1, 2024
Office Director
Center for Drug Evaluation and Research (CDER)
Closing date: April 23, 2024
Physician (Interventional Pulmonologist)
Center for Devices and Radiological Health (CDRH)
Closing date: April 30, 2024
Program and Change Manager
Office of the Commissioner (OC)
Closing date: May 1, 2024
Branch Chief
Center for Biologics Evaluation and Research (CBER)
Closing date: April 21, 2024
Supervisory General Health Scientist
Center for Drug Evaluation and Research (CDER)
Closing date: April 22, 2024
Information Technologist (Program Manager)
Center for Devices and Radiological Health (CDRH)
Closing date: April 26, 2024
Senior Advisor
Office of the Commissioner
Closing date: April 30, 2024
Physician (Internist)
Center for Drug Evaluation and Research (CDER)
Closing date: April 30, 2024
Consumer Safety Officer (Lead)
Center for Biologics Evaluation and Research (CBER)
Closing date: April 26, 2024
Pharmacologist/Toxicologist
Center for Drug Evaluation and Research (CDER)
Closing date: April 24, 2024
Biologist
Center for Drug Evaluation and Research (CDER)
Closing date: April 24, 2024
Division Director
Center for Biologics Evaluation and Research (CBER)
Closing date: April 22, 2024
Physician
Center for Biologics Evaluation and Research (CBER)
Closing date: Open continuously; applications will be reviewed periodically
Investigator II/Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 22, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: July 10, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: May 31, 2024
Physician, Office of Therapeutic Products (OTP)
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically
Physician
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically.